C-MER Medical Holdings Limited (HKG:3309)
Hong Kong · Delayed Price · Currency is HKD 0.8500
-0.0050 (-0.58%)
Sep 2, 2026, 3:20 PM HKT
C-MER Medical Holdings Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,027 | 1,947 | 1,913 | 1,924 | 1,732 | 1,113 | |
Revenue Growth | 4.75% | 1.75% | -0.56% | 11.09% | 55.67% | 59.04% |
Cost of Revenue | 1,394 | 1,343 | 1,316 | 1,305 | 1,284 | 754.35 |
Gross Profit | 633.13 | 603.67 | 596.9 | 618.96 | 447.7 | 358.23 |
Selling, General & Admin | 481.26 | 471.38 | 475.98 | 502.73 | 472.12 | 360.56 |
Other Operating Expenses | -15.89 | -10.98 | -8.09 | -8.41 | -28.65 | -10.58 |
Operating Expenses | 466.03 | 461.07 | 468.01 | 494.45 | 443.47 | 349.98 |
Operating Income | 167.09 | 142.6 | 128.89 | 124.51 | 4.22 | 8.25 |
Interest Expense | -20.9 | -24.34 | -23.66 | -18.12 | -19.66 | -13 |
Interest & Investment Income | 8.45 | 12.97 | 14.57 | 19.89 | 7.11 | 4.48 |
Earnings From Equity Investments | 0.69 | -0.58 | -0.98 | 3.16 | 37.8 | 10.65 |
Currency Exchange Gain (Loss) | 0.28 | -1.89 | -0.45 | -3.05 | -7.06 | 4.44 |
EBT Excluding Unusual Items | 155.61 | 128.76 | 118.38 | 126.39 | 22.42 | 14.83 |
Impairment of Goodwill | -2.52 | -0.65 | -77.94 | - | - | - |
Gain (Loss) on Sale of Investments | 7.46 | 11.65 | 3.44 | -10.74 | -33.22 | 16.71 |
Gain (Loss) on Sale of Assets | -0.4 | 2.38 | -1.43 | -0.12 | -0.43 | -5.12 |
Asset Writedown | -0.82 | -2.52 | -122.04 | -2.5 | - | - |
Other Unusual Items | 1.79 | 15.89 | 2.59 | 11.24 | - | 0.45 |
Pretax Income | 161.11 | 155.52 | -76.22 | 124.27 | -11.23 | 26.88 |
Income Tax Expense | 49.07 | 44.35 | 32.09 | 37.93 | 35 | 10.65 |
Earnings From Continuing Operations | 112.04 | 111.17 | -108.31 | 86.34 | -46.23 | 16.23 |
Minority Interest in Earnings | -11.6 | -10.81 | -26.85 | -24.34 | 24.35 | 5.63 |
Net Income | 100.44 | 100.37 | -135.16 | 62 | -21.88 | 21.86 |
Net Income to Common | 100.44 | 100.37 | -135.16 | 62 | -21.88 | 21.86 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,193 | 1,206 | 1,233 | 1,256 | 1,233 | 1,148 |
Shares Outstanding (Diluted) | 1,193 | 1,206 | 1,233 | 1,256 | 1,233 | 1,151 |
Shares Change | -2.25% | -2.25% | -1.77% | 1.82% | 7.16% | 4.22% |
EPS (Basic) | 0.08 | 0.08 | -0.11 | 0.05 | -0.02 | 0.02 |
EPS (Diluted) | 0.08 | 0.08 | -0.11 | 0.05 | -0.02 | 0.02 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 205.77 | 124.51 | 245.67 | 75.86 | 26.26 |
Free Cash Flow Per Share | - | 0.17 | 0.10 | 0.20 | 0.06 | 0.02 |
Dividend Per Share | 0.020 | 0.020 | 0.020 | - | - | - |
Dividend Growth | 0% | 0% | 0% | - | - | - |
Gross Margin | 31.24% | 31.01% | 31.20% | 32.17% | 25.85% | 32.20% |
Operating Margin | 8.24% | 7.32% | 6.74% | 6.47% | 0.24% | 0.74% |
Profit Margin | 4.96% | 5.16% | -7.07% | 3.22% | -1.26% | 1.97% |
Free Cash Flow Margin | - | 10.57% | 6.51% | 12.77% | 4.38% | 2.36% |
EBITDA | 230.21 | 206.52 | 202.46 | 204.02 | 92.28 | 60.03 |
EBITDA Margin | 11.36% | 10.61% | 10.58% | 10.60% | 5.33% | 5.40% |
D&A For EBITDA | 63.11 | 63.91 | 73.57 | 79.51 | 88.06 | 51.78 |
EBIT | 167.09 | 142.6 | 128.89 | 124.51 | 4.22 | 8.25 |
EBIT Margin | 8.24% | 7.32% | 6.74% | 6.47% | 0.24% | 0.74% |
Effective Tax Rate | 30.46% | 28.52% | - | 30.53% | - | 39.61% |
Advertising Expenses | - | 138.38 | 131.02 | 145.61 | 125.65 | 125.66 |